Qiagen (QGEN) Cash from Financing Activities (2010 - 2026)
Qiagen (QGEN) posted Cash from Financing Activities of -$503.7 million for Q1 2026, down 5.37% sequentially from -$478.0 million in Q4 2025, and down 75.67% YoY from -$2.1 billion in Q1 2025.
Qiagen (QGEN) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Qiagen has reported Cash from Financing Activities for 16 years, with the latest figure at -$503.7 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 75.67% year-over-year to -$503.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$395.6 million (up 5.17% YoY) and the FY2025 annual result came in at -$179.0 million, up 57.68% from the prior year.
- Cash from Financing Activities eased to -$503.7 million in Q1 2026 per QGEN's latest filing, from -$478.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $614.1 million in Q3 2025 and troughed at -$503.7 million in Q1 2026.
- A 5-year average of -$73.2 million and a median of -$28.0 million in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 983.74% in 2022, then plunged 6012.5% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$126.0 million in 2022, then soared by 93.65% to -$8.0 million in 2023, then slumped by 6012.5% to -$489.0 million in 2024, then climbed by 2.25% to -$478.0 million in 2025, then slipped by 5.37% to -$503.7 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$503.7 million, -$478.0 million, and $614.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Qiagen | 8.65 Bn | 8.65 Bn | - | -503.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -503.66 Mn |
| Mar 31, 2026 | -503.66 Mn |
| Dec 31, 2025 | -478.00 Mn |
| Dec 31, 2025 | -478.00 Mn |
| Sep 30, 2025 | 614.07 Mn |
| Sep 30, 2025 | 614.07 Mn |
| Jun 30, 2025 | -28.00 Mn |
| Jun 30, 2025 | -28.00 Mn |
| Mar 31, 2025 | -286.70 Mn |
| Mar 31, 2025 | -286.70 Mn |
| Dec 31, 2024 | -489.00 Mn |
| Dec 31, 2024 | -489.00 Mn |
| Sep 30, 2024 | 485.55 Mn |
| Sep 30, 2024 | 485.55 Mn |
| Jun 30, 2024 | -127.00 Mn |
| Jun 30, 2024 | -127.00 Mn |
| Mar 31, 2024 | -292.09 Mn |
| Mar 31, 2024 | -292.09 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Dec 31, 2023 | -8.00 Mn |